Dusseldorf-based medtech CUREosity has raised €3.8 million to further develop its therapy software. The fresh capital saw participation from existing investors, including TechVision Fonds (TVF), and the Belgian family office Nomainvest.
- Founded in 2018 by Thomas Saur, Stefan Arand, and Marco Faulhammer, CUREosity is a medtech startup focusing on virtual reality therapy through gamification. The startup develops virtual reality therapy applications for clinics and practices, offering evidence-based success, sustainable personnel relief, increased patient motivation, and intuitive usability.
- The startup employs a team of 50 scientists, doctors, and therapists to improve therapy effectiveness. Furthermore, CUREosity operates in almost 200 therapeutic facilities across 24 European countries, including Belgium, Luxembourg, Germany, the Netherlands, Austria, and Switzerland.
Details of the deal
- The fresh capital was backed by existing inventors, including TechVision Fond (TVF), an Aachen-based venture capital firm that invests in medical tech startups, and Eupen-based Nomainvest, a family private equity investment firm that funds startups across Belgium, Germany, France, Luxembourg, and the Netherlands.
“CUREosity solves the problem of the shortage of skilled workers in the field of therapy. Demographic change in particular makes smart solutions such as CURE highly relevant to society. We are pleased to be able to participate in the solutions and successes in the future,” partner at TVF, Björn Lang, commented.
- With the funding raised, CUREosity aims to expand its market leadership in the VR therapy sector and enhance the quality of updates to its therapy software.
"The current success story, consisting of scaling markets and high-quality updates to our therapy software, is strengthened by this financing. We plan to invest intensively in commercial expansion and incorporate the technological possibilities of tomorrow into our product roadmap today. With this financing round, we can ensure financial independence and sustainable business. A privilege, especially in tense market conditions,” CEO at CUREosity, Caesar van Heyningen, stated.
